ijcm International Journal of Clinical Medicine 2158-2882 2158-284X Scientific Research Publishing 10.4236/ijcm.2026.173005 ijcm-150082 Article Medicine Healthcare Effect of Exercise Training Combined with Galantamine on Neurological Function and Muscle Strength Recovery in Patients with Hemiplegia after Acute Ischemic Stroke Liang Yuru 1 2 Liang Dongxu 3 Huang Longjian 1 † Clinical Medical College of Youjiang Medical University for Nationalities, Baise, China The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China School of Public Health and Management, Guangxi University of Chinese Medicine, Nanning, China

These authors contributed equally to this work.

The authors declare no conflicts of interest regarding the publication of this paper.

 12 03 2026 03 2026 17 03 63 72 14 02 2026 09 03 2026 12 03 2026 © 2026 by the authors and Scientific Research Publishing Inc. 2026 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ ). https://doi.org/10.4236/ijcm.2026.173005

Objective: To analyze the effect of exercise training combined with galantamine hydrobromide injection on the neurological and motor function of patients with hemiplegia after acute ischemic stroke. Methods: A total of 100 patients with acute ischemic stroke admitted to the Department of Neurology of our hospital from April 2025 to February 2026 were selected as the study subjects. According to the intervention protocol, they were divided into an observation group (50 cases receiving galantamine + conventional treatment + exercise training) and a control group (50 cases receiving conventional treatment + exercise training). General clinical data were collected from both groups, and assessments were performed before and after intervention using the National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (mRS), and Manual Muscle Test (MMT). Results: There were no statistically significant differences in gender, age, TOAST classification, or disease course between the observation group and the control group of patients with acute ischemic stroke hemiplegia (P > 0.05). Compared between the observation group and the control group, the MMT values were significantly higher after treatment than before, with statistically significant differences (P < 0.001), while no statistically significant difference was observed between the two groups (P > 0.05). After treatment, the mRS scores and NIHSS scores in both groups decreased significantly compared to pre-treatment levels (P < 0.001), with the observation group showing significantly lower scores than the control group (P < 0.001). No statistically significant difference was observed in upper limb muscle strength efficacy between the two groups (χ2 = 5.93, P > 0.05), whereas a statistically significant difference was noted in lower limb muscle strength efficacy (χ2 = 16.07, P < 0.001). The efficacy rate of the observation group (54.00%) was significantly higher than that of the control group (16.00%). Pairwise comparisons revealed statistically significant differences in the efficacy rates of lower limb muscle strength between the two groups (P < 0.05). Conclusion: Galantamine combined with exercise training can promote the recovery of neurological function and muscle strength in patients with acute ischemic stroke, improve the ability of daily living activities.

 Galantamine Exercise Training Acute Ischemic Stroke Neurological Function Recovery Retrospective Analysis 1. Background

Stroke is an acute cerebrovascular disease caused by sudden rupture or occlusion of cerebral blood vessels, leading to impaired blood flow to the brain and subsequent damage to brain tissue [1]. Among these, acute ischemic stroke (AIS) accounts for approximately 80% of all stroke cases, characterized by rapid onset, high disability rate, and high recurrence rate. Post-onset, insufficient cerebral blood perfusion induces ischemic and hypoxic damage to neurons, leaving about 60% - 70% of surviving patients with varying degrees of motor and cognitive dysfunction, severely affecting their quality of life and imposing a heavy burden on society and families [2]-[4]. Current clinical standard treatments primarily focus on antiplatelet aggregation, platelet stabilization, improvement of cerebral circulation, and neurotrophic support, while comprehensive rehabilitation therapy demonstrates synergistic neuroplasticity effects [5]. Exercise training, as a core rehabilitation approach for AIS, can improve limb motor function by promoting neuroplasticity; however, single exercise training has limited efficacy in patients with moderate to severe neurological deficits [6][7]. Galantamine, a reversible and highly selective acetylcholinesterase inhibitor, increases synaptic acetylcholine concentration, enhances cholinergic neurotransmission, and improves neurological and cognitive functions [8]-[10]. Recent studies have confirmed the neuroprotective effects of galantamine in the ultra-early stages of AIS, which may involve reducing cytotoxic edema and protecting damaged neural tissues [11].

Previous studies have predominantly focused on the single-intervention effects of galantamine or exercise training, with limited clinical research on their combined application, and their practical efficacy still requires further validation. This study retrospectively analyzed clinical data of AIS patients admitted to our hospital to compare the intervention effects of galantamine combined with exercise training versus single exercise training, providing a practical basis for the clinical promotion and application of combined intervention protocols.

 2. Materials and Methods 2.1. General Data

A retrospective study was conducted on 100 patients with acute ischemic stroke admitted to the Department of Neurology at the Affiliated Hospital of Youjiang Medical University for Nationalities from April 2025 to February 2026, using data from the hospital’s electronic medical record system (HIS), imaging information management system (Hinacom), and rehabilitation department medical records. This study was approved by the Ethics Committee of the Affiliated Hospital of Youjiang Medical University for Nationalities, and all patients provided informed consent.

Inclusion criteria: ① Meet the AIS diagnostic criteria in the “China Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023” [1], confirmed as cerebral infarction by cranial CT/MRI examination, and exclude cerebral hemorrhage; ② The onset time is ≤72 hours, vital signs are stable, and there is clear motor dysfunction; ③ Complete clinical data, including general information, imaging examinations, laboratory tests, treatment plans, efficacy evaluation, and follow-up records; ④ Able to cooperate in completing motor training and various assessments; ⑤ The patient or family member signs the informed consent for clinical diagnosis and treatment.

Exclusion criteria: ① Concomitant brain tumors, central nervous system infections, cerebrovascular malformations, or other brain disorders; ② Allergy to galantamine or contraindications to cholinesterase inhibitors; ③ Severe functional failure of vital organs (heart, liver, kidneys, lungs) or coagulation disorders; ④ Mental disorders or cognitive impairments preventing assessment cooperation; ⑤ Incomplete follow-up data, intervention discontinuation, or hospital transfer.

Patients were divided into an observation group and a control group, each consisting of 50 cases, based on whether they received exercise training combined with galantamine hydrobromide injection during hospitalization. The observation group received conventional basic treatment plus galantamine and individualized exercise training, while the control group received conventional basic treatment plus individualized exercise training. Data from both groups were collected as follows: ① General demographic data: gender, age; ② Disease-related data: time to onset, Trial of Org 10172 in Acute Stroke Treatment (TOAST), baseline National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (mRS), and Manual Muscle Test (MMT); ③ Efficacy evaluation data: NIHSS, mRS, MMT before and after treatment.

 2.2. Intervention Protocol

Both groups received individualized treatment plans jointly developed by neurologists and rehabilitation physicians, with exercise training conducted under one-on-one guidance by professional rehabilitation therapists.

2.2.1. Conventional Basic Treatment

Both groups received standard AIS treatment: antiplatelet aggregation (aspirin 100 mg qd or clopidogrel 75 mg qd); statins for lipid-lowering and plaque stabilization (atorvastatin 20 mg qn or rosuvastatin 10 mg qn); cerebral circulation improvement (butylphthalide, edaravone, etc.); neurotrophic support (sodium citicoline, etc.); while controlling risk factors such as blood pressure, blood glucose, and blood lipids, and providing symptomatic supportive therapy.

2.2.2. Individualized Exercise

Training Both groups initiated training within 48 hours after disease stabilization (stable vital signs and no progression of neurological deficits for 48 hours). The intensity should be such that patients experienced mild fatigue without significant pain (VAS score < 3). Training content: Week 1 focused on passive joint mobility training (flexion/extension and rotation of the affected shoulder, elbow, wrist, hip, knee, and ankle joints) and core stability training (bridge exercise). Week 2 gradually introduced active exercises: active resistance training (straight leg raises, shoulder flexion, wall-supported static squats), balance and gait training (transition from seated to standing balance, assisted gait training with crutches/assistive devices). Training was conducted once daily for 40 minutes, 5 days per week, over a 2-week course.

2.2.3. Galantamine Administration

The observation group received intramuscular injection of Galantamine Hydrobromide Injection (Shanghai Xudong Haipu Pharmaceutical Co, Ltd, National Drug Approval Number H31020671,1 mL: 5 mg) in addition to the aforementioned regimen, at a dose of 5 mg per injection, once daily, for a treatment course of 2 weeks.

 2.3. Observation Indicators

2.3.1. Clinical Outcomes

Before treatment (admission) and after treatment (discharge): ① NIHSS score (0-42 points): Higher scores indicate more severe neurological deficits; ② mRS score (0 - 6 points): Higher scores indicate more severe neurological impairment; ③ Manual Muscle Test (MMT) assessment, total score 0 - 5 points, lower scores indicate weaker muscle strength and poorer motor function.

2.3.2. Evaluation of Muscle Strength Recovery [12]

A treatment is considered to have demonstrated significant efficacy if the muscle strength grade improves by two or more levels, or if the muscle strength grade is restored to grade V. If the muscle strength grade improves by one level but does not reach grade V, the treatment is deemed effective. If no improvement in muscle strength grade is observed, the treatment is classified as ineffective.

 2.4. Statistical Analysis

Data analysis was performed using SPSS 23.0 software. Measurement data conforming to normal distribution were described using ( x ¯ ± s ). Between-group comparisons were conducted using the independent samples t-test, while within-group comparisons were performed using the paired t-test. Measurement data non-conforming to normal distribution were expressed as [M (P25, P75)], with between-group comparisons using the Mann-Whitney U rank-sum test and within-group comparisons using the Wilcoxon rank-sum test. Categorical data were presented as n (%) and compared between groups using the chi-square test with two-tailed testing at an alpha level of 0.05.

 3. Results 3.1. Comparison of General Clinical Data between the Observation Group and the Control Group of Patients with Hemiplegia Due to Acute Ischemic Stroke

No statistically significant differences were observed in gender, age, TOAST classification, disease course between the observation group and the control group of patients with acute ischemic stroke and hemiplegia (P > 0.05) (Table 1).

Table 1. Comparison of general data between the observation group and control group of patients with hemiplegia due to acute ischemic stroke.

Metric Observation group ( n = 50) Control group ( n = 50) X 2 /t/z P
Sex [n(%)] Male 38 (76.0) 29 (58.0) 3.66 0.06
Female 12 (24.0) 21 (42.0)
Age [years/( x ¯ ± s )] 63 ± 11 61 ± 9 −1.46 0.15
TOAST typing [n (%)] Atherosclerotic type of large arteries 41 (82.0) 33 (66.0) 3.33 0.07
Arteriole occlusive type 9 (18.0) 17 (34.0)
Course of disease [h/M ( P 25 , P 75 )] 14.50 (7.00, 24.00) 16.00 (6.00, 24.00) −0.01 0.99

Note: The observation group received conventional basic treatment plus galantamine and individualized exercise training, while the control group received conventional basic treatment plus individualized exercise training.

 3.2. Comparison of MMT, mRS, and NIHSS Scores before and after Treatment in Patients with Acute Ischemic Stroke Hemiplegia in the Observation Group and Control Group

Compared between the observation group and the control group, the MMT values were significantly higher after treatment than before, with statistically significant differences (P < 0.001). No statistically significant difference was observed in MMT between the two groups (P > 0.05) (Table 2).

After treatment, both the observation group and control group showed statistically significant decreases in mRS and NIHSS scores compared to pre-treatment levels (P < 0.001). Notably, the mRS and NIHSS scores in the observation group were significantly lower than those in the control group, with a statistically significant difference (P < 0.001) (Table 3).

Table 2. Comparison of MMT before and after treatment between the two groups of patients [M (P25, P75)].

Group Upper limb muscle strength Lower limb muscle strength
Before intervention After the intervention z P Before intervention After the intervention z P
Observation group 3.00 (2.00, 3.25) 4.00 (3.00, 5.00) −5.836 <0.001 3.00 (2.00, 4.00) 4.00 (3.00, 5.00) −5.679 <0.001
Control group 3.00 (2.00, 4.00) 4.00 (3.00, 4.00) −5.129 <0.001 3.00 (2.75, 4.00) 4.00 (3.00, 4.00) −5.523 <0.001
z −1.172 −1.719
P 0.241 0.086

Table 3. Comparison of mRS scores and NIHSS scores before and after treatment between the two groups [M (P25, P75)].

Group mRS grade NIHSS grade
Before intervention After the intervention z P Before intervention After the intervention z P
Observation group 4.00 (4.00, 4.00) 2.00 (1.00, 3.25) −5.778 <0.001 7.00 (5.00, 9.25) 2.00 (1.00, 4.25) −6.109 <0.001
Control group 4.00 (4.00, 4.00) 3.00 (2.00, 4.00) −5.282 <0.001 5.00 (4.00, 9.00) 3.50 (2.00, 6.00) −5.825 <0.001
z −3.63 −3.94
P <0.001 <0.001

Note: NIHSS is the National Institutes of Health Stroke Scale, and mRS is the Modified Rankin Scale (mRS).

 3.3. Comparison of Clinical Efficacy between the Observation Group and the Control Group in Patients with Acute Ischemic Stroke and Hemiplegia

In the observation group, the rates of significant improvement, effective, and ineffective upper limb muscle strength were 26 cases (52.00%), 17 cases (34.00%), and 7 cases (14.00%), respectively. In the control group, the rates were 16 cases (32.00%), 18 cases (36.00%), and 16 cases (32.00%), respectively. There was no statistically significant difference in the efficacy of upper limb muscle strength between the observation group and the control group (χ2 = 5.93, P > 0.05). However, there was a statistically significant difference in the efficacy of lower limb muscle strength between the two groups (χ2 = 16.07, P < 0.001). The rate of significant improvement in the observation group (54.00%) was higher than that in the control group (16.00%). Pairwise comparisons revealed statistically significant differences in the rates of significant improvement, effective, and ineffective efficacy between the two groups (P < 0.05) (Table 4).

Table 4. Comparison of muscle strength efficacy between the two groups [n (%)].

Group Upper limb muscle strength efficacy Lower limb muscle strength efficacy
Excellence Valid of no avail Excellence Valid of no avail
Observation group 26 (52.00) 17 (34.00) 7 (14.00) 27 (54.00) 14 (28.00) 9 (18.00)
Control group 16 (32.00) 18 (36.00) 16 (32.00) 8 (16.00) 28 (56.00) 14 (28.00)
Statistics 5.93 16.07
P >0.05 <0.001
4. Discussion

The pathophysiological mechanism of acute ischemic stroke involves ischemic-hypoxic damage to neurons caused by insufficient cerebral blood flow perfusion. In the infarct core region, neurons undergo rapid irreversible necrosis, while those in the ischemic penumbra remain in a state of reversible injury. The core clinical treatment objectives are to promptly salvage the ischemic penumbra, mitigate neuronal damage, promote neurological function recovery, and reduce disability rates [13][14]. The cholinergic system participates in the complex pathophysiological processes following ischemic stroke, playing a critical role in secondary neuronal damage during both the acute and chronic phases of brain injury. Additionally, the cholinergic system in neurons is essential for regulating cognitive functions, sensory perception, and motor control [15][16]. Our study demonstrated that the observation group achieved significantly lower NIHSS and mRS scores compared to the control group post-treatment, with superior recovery of lower limb muscle strength on the hemiplegic side. This suggests that galantamine and exercise training exhibit a significant synergistic intervention effect, with combined application yielding better outcomes than exercise training alone. However, no significant improvement was observed in upper limb muscle strength. Post-stroke hemiplegic patients exhibit slower recovery of upper limb function, with approximately half of the patients still experiencing upper limb motor dysfunction years after onset. These findings align with the clinical patterns and underlying mechanisms of upper limb recovery in stroke hemiplegia [17][18].

This study, based on clinical diagnostic and therapeutic data, retrospectively analyzed that galantamine combined with exercise training can enhance the short-term intervention effects in patients with acute ischemic stroke (AIS), demonstrating a synergistic mechanism that promotes neurological function and muscle strength recovery on the hemiplegic side, consistent with previous research findings [8][11][19]. The two interventions may exert a cumulative effect through multiple pathways: On one hand, as a highly selective acetylcholinesterase inhibitor, galantamine specifically inhibits acetylcholinesterase activity, increasing acetylcholine concentration in the synaptic cleft of the ischemic area, improving cholinergic pathway signaling, reducing neurotoxic edema, maintaining the integrity of the corticospinal tract, and activating cholinergic receptors to promote the synthesis and release of neurotrophic factors in the brain, thereby laying the foundation for neural repair [20][21]. On the other hand, exercise training reduces the volume of cerebral infarction, attenuates the expression of apoptosis factors, and increases the expression of growth factors, maximizing the compensatory capacity of the perilesional cortex and promoting cerebral metabolism, thereby restoring neurological and motor functions and shortening rehabilitation time [22][23]. When combined, galantamine enhances the neuroplasticity-promoting effects of exercise training, while exercise training amplifies the neuroprotective effects of galantamine, more effectively salvaging ischemic penumbra neurons.

This study still has certain limitations: it is a single-center retrospective study with a limited sample size, and the generalizability of the results requires further validation through multicenter, large-sample studies. Only the short-term efficacy of the intervention was assessed, without long-term follow-up, making it impossible to determine the impact of the combined regimen on long-term patient outcomes. Future research could involve multicenter, large-sample prospective controlled studies with extended follow-up to provide more robust evidence for developing individualized clinical strategies.

 5. Conclusion

In conclusion, the combination of galantamine and exercise training in patients with hemiplegia due to acute ischemic stroke can reduce the degree of neurological deficits and promote muscle strength recovery. Moreover, the two interventions exhibit a synergistic effect, demonstrating superior efficacy compared to exercise training alone. This combined approach provides a novel and effective option for the comprehensive clinical management of acute ischemic stroke, offering significant value for clinical application and promotion.

 NOTES

*Co-first authors, equal contribution.

#Corresponding author.

 References Chinese Medical Association Neurology Branch, Cerebrovascular Disease Group of Chinese Medical Association Neurology Branch (2024) China Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023. ChineseJournalofNeurology, 57, 523-559. Branch, C 2024 China Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023 Chinese Journal of Neurology 57 Stroke Prevention Project, National Health Commission Jixunming (2025) Brief Report on Stroke Prevention and Treatment in China, 2024. JournalofCapitalMedicalUniversity, 46, 947-960. Project, N 2025 Brief Report on Stroke Prevention and Treatment in China, 2024 Journal of Capital Medical University 46 Zhao, Y., Hua, X., Ren, X., Ouyang, M., Chen, C., Li, Y., et al. (2022) Increasing Burden of Stroke in China: A Systematic Review and Meta-Analysis of Prevalence, Incidence, Mortality, and Case Fatality. InternationalJournalofStroke, 18, 259-267. https://doi.org/10.1177/17474930221135983 10.1177/1747493022113598336274585https://doi.org/10.1177/17474930221135983 Zhao, Y. Hua, X. Ren, X. Ouyang, M. Chen, C. Li, Y. Prevalence, I 2022 Increasing Burden of Stroke in China: A Systematic Review and Meta-Analysis of Prevalence, Incidence, Mortality, and Case Fatality International Journal of Stroke 18 10.1177/17474930221135983 36274585 Herpich, F. and Rincon, F. (2020) Management of Acute Ischemic Stroke. CriticalCareMedicine, 48, 1654-1663. https://doi.org/10.1097/ccm.0000000000004597 10.1097/ccm.000000000000459732947473https://doi.org/10.1097/ccm.0000000000004597 Herpich, F. Rincon, F. 2020 Management of Acute Ischemic Stroke Critical Care Medicine 48 10.1097/ccm.0000000000004597 32947473 Moskiewicz, D. and Sarzyńska-Długosz, I. (2025) Modern Technologies Supporting Motor Rehabilitation after Stroke: A Narrative Review. JournalofClinicalMedicine, 14, Article No. 8035. https://doi.org/10.3390/jcm14228035 10.3390/jcm14228035https://doi.org/10.3390/jcm14228035 Moskiewicz, D. 2025 Modern Technologies Supporting Motor Rehabilitation after Stroke: A Narrative Review Journal of Clinical Medicine 14 No 10.3390/jcm14228035 Zhang, W., Lou, B., Li, J., Shi, W., Liu, X., Tang, J., et al. (2021) Clinical Practice Guidelines of Chinese Medicine Rehabilitation for Ischemic Stroke (Cerebral Infarction). RehabilitationMedicine, 31, 437-447. https://doi.org/10.3724/sp.j.1329.2021.06001 10.3724/sp.j.1329.2021.06001https://doi.org/10.3724/sp.j.1329.2021.06001 Zhang, W. Lou, B. Li, J. Shi, W. Liu, X. Tang, J. 2021 Clinical Practice Guidelines of Chinese Medicine Rehabilitation for Ischemic Stroke (Cerebral Infarction) Rehabilitation Medicine 31 10.3724/sp.j.1329.2021.06001 Zhang, L., Wang, X.-L., Wu, Y., et al. (2022) Effects of Graded Exercise on the Neurological Function and Self-Care Ability of Patients with Ischemic Stroke. HealthMedicineResearchandPractice, 19, 90-92+96. Zhang, L. Wang, X. Wu, Y. 2022 Effects of Graded Exercise on the Neurological Function and Self-Care Ability of Patients with Ischemic Stroke Health Medicine Research and Practice 19 Zheng, S. and Tang, X.R. (2020) Clinical Efficacy of Cytidine Diphosphate Choline Combined with Galantamine in the Treatment of Cerebral Infarction. Shenzhen JournalofIntegratedTraditionalChineseandWesternMedicine, 30, 104-105. Zheng, S. Tang, X.R. 2020 Clinical Efficacy of Cytidine Diphosphate Choline Combined with Galantamine in the Treatment of Cerebral Infarction Shenzhen Journal of Integrated Traditional Chinese and Western Medicine 30 Lin, S.Q. and Zhang, Y.Q. (2026) Efficacy of Galantamine Combined with Flunarizine in the Treatment of Patients with Acute Ischemic Cerebrovascular Disease. Chinese Journal of Drug Application and Monitoring, 23, 72-76. Lin, S.Q. Zhang, Y.Q. 2026 Efficacy of Galantamine Combined with Flunarizine in the Treatment of Patients with Acute Ischemic Cerebrovascular Disease Chinese Journal of Drug Application and Monitoring 23 Zhou, H., Yao, W., Shan, Q., Zhang, X., Zhang, D., Che, J., et al. (2024) Hierarchical Adhesive Hydrogel Microparticles with Galantamine Hydrobromide Encapsulation for the Treatment of Alzheimer’s Disease. Materials&Design, 246, Article ID: 113322. https://doi.org/10.1016/j.matdes.2024.113322 10.1016/j.matdes.2024.113322https://doi.org/10.1016/j.matdes.2024.113322 Zhou, H. Yao, W. Shan, Q. Zhang, X. Zhang, D. Che, J. 2024 Hierarchical Adhesive Hydrogel Microparticles with Galantamine Hydrobromide Encapsulation for the Treatment of Alzheimer’s Disease Materials & Design 246 113322 ID 10.1016/j.matdes.2024.113322 Zhao, H., Chen, Z.W. and Yang, D.D. (2025) Observation of the Effect of Galantamine on Motor Function in Patients with Cerebral Infarction at Different Stages Using 3D-DTI Technology. ChineseJournalofNeurosurgicalDiseaseResearch, 19, 118-123. Zhao, H. Chen, Z.W. Yang, D.D. 2025 Observation of the Effect of Galantamine on Motor Function in Patients with Cerebral Infarction at Different Stages Using 3D-DTI Technology Chinese Journal of Neurosurgical Disease Research 19 Petersen, C.B., Eriksen, L., Dahl-Petersen, I.K., Aadahl, M. and Tolstrup, J.S. (2021) Self-Rated Physical Fitness and Measured Cardiorespiratory Fitness, Muscular Strength, and Body Composition. ScandinavianJournalofMedicine&ScienceinSports, 31, 1086-1095. https://doi.org/10.1111/sms.13918 10.1111/sms.1391833458890https://doi.org/10.1111/sms.13918 Petersen, C.B. Eriksen, L. Dahl-Petersen, I.K. Aadahl, M. Tolstrup, J.S. Fitness, M 2021 Self-Rated Physical Fitness and Measured Cardiorespiratory Fitness, Muscular Strength, and Body Composition Scandinavian Journal of Medicine & Science in Sports 31 10.1111/sms.13918 33458890 Shi, H.Y., Qian, W.Y., Wang, K.F., et al. (2025) Research Progress of MRI in Blood-Brain Barrier Injury Associated with Acute Ischemic Stroke. ChineseJournalofMagneticResonanceImaging, 16, 154-159. Shi, H.Y. Qian, W.Y. Wang, K.F. 2025 Research Progress of MRI in Blood-Brain Barrier Injury Associated with Acute Ischemic Stroke Chinese Journal of Magnetic Resonance Imaging 16 Cao, G.H. (2025) The Role and Mechanism of LRRC8A in Cerebral Ischemia-Reperfusion Injury. Air Force Medical University of the People’s Liberation Army. Cao, G.H. 2025 The Role and Mechanism of LRRC8A in Cerebral Ischemia-Reperfusion Injury Wang, X.T., Wang, P.Q. and Sun, W.J. (2026) Advances in the Role of Cholinergic Anti-Inflammatory Pathway in Post-Stroke Cognitive Impairment. ChineseJournalofGeriatricCardiovascularandCerebrovascularDiseases, 28, 271-273. Wang, X.T. Wang, P.Q. Sun, W.J. 2026 Advances in the Role of Cholinergic Anti-Inflammatory Pathway in Post-Stroke Cognitive Impairment Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases 28 Halder, N., Yadav, S. and Lal, G. (2024) Neuroimmune Communication of the Cholinergic System in Gut Inflammation and Autoimmunity. AutoimmunityReviews, 23, Article ID: 103678. https://doi.org/10.1016/j.autrev.2024.103678 10.1016/j.autrev.2024.10367839500481https://doi.org/10.1016/j.autrev.2024.103678 Halder, N. Yadav, S. Lal, G. 2024 Neuroimmune Communication of the Cholinergic System in Gut Inflammation and Autoimmunity Autoimmunity Reviews 23 103678 ID 10.1016/j.autrev.2024.103678 39500481 Abdullahi, A., Wong, T.W.L. and Ng, S.S.M. (2023) Variation in the Rate of Recovery in Motor Function between the Upper and Lower Limbs in Patients with Stroke: Some Proposed Hypotheses and Their Implications for Research and Practice. FrontiersinNeurology, 14, Article ID: 1225924. https://doi.org/10.3389/fneur.2023.1225924 10.3389/fneur.2023.122592437602245https://doi.org/10.3389/fneur.2023.1225924 Abdullahi, A. Wong, T.W.L. Ng, S.S.M. 2023 Variation in the Rate of Recovery in Motor Function between the Upper and Lower Limbs in Patients with Stroke: Some Proposed Hypotheses and Their Implications for Research and Practice Frontiers in Neurology 14 122592 ID 10.3389/fneur.2023.1225924 37602245 Wang, X., Fu, Y., Ye, B., Babineau, J., Ding, Y. and Mihailidis, A. (2022) Technology-Based Compensation Assessment and Detection of Upper Extremity Activities of Stroke Survivors: Systematic Review. JournalofMedicalInternetResearch, 24, e34307. https://doi.org/10.2196/34307 10.2196/3430735699982https://doi.org/10.2196/34307 Wang, X. Fu, Y. Ye, B. Babineau, J. Ding, Y. Mihailidis, A. 2022 Technology-Based Compensation Assessment and Detection of Upper Extremity Activities of Stroke Survivors: Systematic Review Journal of Medical Internet Research 24 10.2196/34307 35699982 Ma, C.L., Tang, J. and Zhang, Y.Q. (2019) Observation on the Curative Effect of Galantamine Injection on Cerebral Infarction Hemiplegia. Contemporary Medicine, 25, 43-45. Ma, C.L. Tang, J. Zhang, Y.Q. 2019 Observation on the Curative Effect of Galantamine Injection on Cerebral Infarction Hemiplegia Contemporary Medicine 25 Liu, J. (2020) Therapeutic Efficacy of Galantamine Hydrobromide Tablets Combined with Vitamin E in the Treatment of Alzheimer’s Disease. PracticalClinicalJournalofIntegratedTraditionalChineseandWesternMedicine, 20, 100-101. Liu, J. 2020 Therapeutic Efficacy of Galantamine Hydrobromide Tablets Combined with Vitamin E in the Treatment of Alzheimer’s Disease Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine 20 Li, F.F. (2025) Study on Clinical Effect of Conventional Treatment Combined with Galantamine Hydrobromide Tablets in the Treatment of Post-Stroke Cognitive Impairment. JournalofChineseandForeignMedicineandPharmacyResearch, 4, 19-21. Li, F.F. 2025 Study on Clinical Effect of Conventional Treatment Combined with Galantamine Hydrobromide Tablets in the Treatment of Post-Stroke Cognitive Impairment Journal of Chinese and Foreign Medicine and Pharmacy Research 4 Du, Y.C., Gao, Y.L., Hou, B.B., et al. (2025) Effects of Intelligent Rehabilitation Robot-Assisted Nustep-T4 Training on Motor Function and Prognosis in Patients with Limb Dysfunction after Acute Ischemic Stroke. HainanMedicalJournal, 36, 1866-1871. Du, Y.C. Gao, Y.L. Hou, B.B. 2025 Effects of Intelligent Rehabilitation Robot-Assisted Nustep-T4 Training on Motor Function and Prognosis in Patients with Limb Dysfunction after Acute Ischemic Stroke Hainan Medical Journal 36 Li, M. (2021) Study on the Effect of Rehabilitation Training Time on the Repair of Acute Ischemic Stroke. Henan University. Li, M. 2021 Study on the Effect of Rehabilitation Training Time on the Repair of Acute Ischemic Stroke